Neogenomics (NEO) Change in Receivables (2010 - 2026)

Neogenomics (NEO) has reported Change in Receivables for 17 consecutive years, with $8.2 million the latest figure, recorded in Q1 2026.

• Change in Receivables for Q1 2026 came in at $8.2 million, up 1124.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.7 million (up 25.28% YoY), and the FY2025 annual result was $6.2 million, down 68.01% from the prior year.
• Change in Receivables was $8.2 million for Q1 2026 at Neogenomics, up from $4.2 million in the prior quarter.
• Over five years, Change in Receivables peaked at $9.1 million in Q1 2024 and troughed at -$1.4 million in Q4 2023.
• Average Change in Receivables over 5 years is $3.1 million, with a median of $2.4 million recorded in 2025.
• The widest YoY moves for Change in Receivables: up 1271.46% in 2023, down 118.3% in 2023.
• Over 5 years, Change in Receivables stood at $7.7 million in 2022, then plunged by 118.3% to -$1.4 million in 2023, then surged by 37.11% to -$888000.0 in 2024, then jumped by 573.76% to $4.2 million in 2025, then jumped by 94.49% to $8.2 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $8.2 million in Q1 2026, $4.2 million in Q4 2025, and $2.4 million in Q3 2025.